Myosin Therapeutics Inc.
2 clinical trials · Sponsor
◉ Watch Myosin Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma (NCT07604285) | Myosin Therapeutics Inc. | 2026-07-01 |
| A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients (NCT07185880) | Myosin Therapeutics Inc. | 2026-04-01 |
Track Myosin Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.